Novel compound heterozygous mutation in NPC1 gene cause Niemann–Pick disease type C with juvenile onset

2020 ◽  
Vol 99 (1) ◽  
Author(s):  
Maria Cristina Costanzo ◽  
Antonio Gennaro Nicotera ◽  
Mirella Vinci ◽  
Aurelio Vitello ◽  
Agata Fiumara ◽  
...  
2014 ◽  
Vol 15 (4) ◽  
pp. 529-541 ◽  
Author(s):  
Kelly A. King ◽  
Sandra Gordon-Salant ◽  
Karen S. Pawlowski ◽  
Anna M. Taylor ◽  
Andrew J. Griffith ◽  
...  

2014 ◽  
Vol 72 (3) ◽  
pp. 214-218 ◽  
Author(s):  
Paulo José Lorenzoni ◽  
Elaine Cardoso ◽  
Ana C. S. Crippa ◽  
Charles Marques Lourenço ◽  
Fernanda Timm Seabra Souza ◽  
...  

The aim of the study was to analyze a series of Brazilian patients with Niemann-Pick disease type C (NP-C). Method Correlations between clinical findings, laboratory data, molecular findings and treatment response are presented. Result The sample consisted of 5 patients aged 8 to 26 years. Vertical supranuclear gaze palsy, cerebellar ataxia, dementia, dystonia and dysarthria were present in all cases. Filipin staining showed the “classical” pattern in two patients and a “variant” pattern in three patients. Molecular analysis found mutations in the NPC1 gene in all alleles. Miglustat treatment was administered to 4 patients. Conclusion Although filipin staining should be used to confirm the diagnosis, bone marrow sea-blue histiocytes often help to diagnosis of NP-C. The p.P1007A mutation seems to be correlated with the “variant” pattern in filipin staining. Miglustat treatment response seems to be correlated with the age at disease onset and disability scale score at diagnosis.


2021 ◽  
Vol 22 (1) ◽  
pp. 452
Author(s):  
Madoka Fukaura ◽  
Yoichi Ishitsuka ◽  
Seiichi Shirakawa ◽  
Naoki Ushihama ◽  
Yusei Yamada ◽  
...  

Niemann–Pick disease type C (NPC) is a recessive hereditary disease caused by mutation of the NPC1 or NPC2 gene. It is characterized by abnormality of cellular cholesterol trafficking with severe neuronal and hepatic injury. In this study, we investigated the potential of glycoprotein nonmetastatic melanoma protein B (GPNMB) to act as a biomarker reflecting the therapeutic effect of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) in an NPC mouse model. We measured serum, brain, and liver expression levels of GPNMB, and evaluated their therapeutic effects on NPC manifestations in the brain and liver after the intracerebroventricular administration of HP-β-CD in Npc1 gene-deficient (Npc1−/−) mice. Intracerebroventricular HP-β-CD inhibited cerebellar Purkinje cell damage in Npc1−/− mice and significantly reduced serum and cerebellar GPNMB levels. Interestingly, we also observed that the intracerebral administration significantly reduced hepatic GPNMB expression and elevated serum ALT in Npc1−/− mice. Repeated doses of intracerebroventricular HP-β-CD (30 mg/kg, started at 4 weeks of age and repeated every 2 weeks) drastically extended the lifespan of Npc1−/− mice compared with saline treatment. In summary, our results suggest that GPNMB level in serum is a potential biomarker for evaluating the attenuation of NPC pathophysiology by intracerebroventricular HP-β-CD treatment.


2014 ◽  
Vol 58 (4) ◽  
pp. 255-61
Author(s):  
Ljerka Cvitanović Šojat ◽  
◽  
Maša Malenica ◽  
Monika Kukuruzović ◽  
Tamara Žigman ◽  
...  

2019 ◽  
Vol 56 (9) ◽  
pp. 6426-6435 ◽  
Author(s):  
Márcia Polese-Bonatto ◽  
Hugo Bock ◽  
Ana Carolina S. Farias ◽  
Rafaella Mergener ◽  
Maria Cristina Matte ◽  
...  

2020 ◽  
Vol 36 (3) ◽  
Author(s):  
Huma Arshad Cheema ◽  
Iqra Ghulam Rasool ◽  
Muhammad Nadeem Anjum ◽  
Muhammad Yasir Zahoor

Objective: Genetic variation analysis of rare autosomal recessive Niemann-Pick disease (NPD) Pakistani patients. Methods: We sequenced the SMPD1 gene including its all coding and flanking regions in seven unrelated sporadic patients suffering from Niemann-Pick disease through targeted exome sequencing. Genetic variants mapping and their protein predictions were evaluated using different bioinformatics tools and clinical phenotypes were correlated. The study was conducted from January 2018 to March 2019 at The Children’s Hospital Lahore. Results: We have mapped five different mutations in SMPD1 gene of enrolled patients with a novel homozygous missense variant (c.1718G>C) (p.Trp573Ser) in one patient. A missense mutation (c.1267C>T) (p.His423Tyr) has been identified in three unrelated patients. A nonsense mutation (c.1327C>T) (p.Arg443Term) and one missense mutation (c.1493G>A) (p.Arg498His) mapped in one patient each. A compound heterozygous mutation has been mapped in one patient (c.740G>A) (p.Gly247Asp); (c.1493G>A) (p.Arg498His). Pathogenic effect of novel variant has been predicted through in-silico analysis and has not been reported in general overall population in the globe. Conclusion: This is the first report of genetic demographic assessment of Niemann-Pick disease in Pakistan. The mapped mutations would be helpful to build a disease variants algorithm of Pakistani population. This will be used for determining disease clinical magnitude along with provision of genetic screening services in affected families. doi: https://doi.org/10.12669/pjms.36.3.467 How to cite this:Cheema HA, Rasool IG, Anjum MN, Zahoor MY. Mutational spectrum of SMPD1 gene in Pakistani Niemann-Pick disease patients. Pak J Med Sci. 2020;36(3):---------. doi: https://doi.org/10.12669/pjms.36.3.467 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


1999 ◽  
Vol 105 (1-2) ◽  
pp. 10-16 ◽  
Author(s):  
Toshiyuki Yamamoto ◽  
Eiji Nanba ◽  
Haruaki Ninomiya ◽  
Katsumi Higaki ◽  
Miyako Taniguchi ◽  
...  

1999 ◽  
Vol 105 (1-2) ◽  
pp. 10-16 ◽  
Author(s):  
T. Yamamoto ◽  
E. Nanba ◽  
H. Ninomiya ◽  
K. Higaki ◽  
H. Zhang ◽  
...  

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Imad Dweikat ◽  
Othman Thaher ◽  
Abdulrahman Abosleem ◽  
Almotazbellah Zeer ◽  
Ameer Abo Mokh

Abstract Background Niemann–Pick disease type C (NPC) is an autosomal recessive, neurodegenerative disease caused by mutations in either the NPC1 or NPC2 genes. Mutations in these genes are associated with abnormal endosomal–lysosomal trafficking, resulting in the accumulation of tissue-specific lipids in lysosomes. Methods We described sixteen patients with NPC diagnosed between the age of 1 month and 30 years at two tertiary care centers in Palestine. The clinical phenotype, brain magnetic resonance imaging (MRI), and molecular genetic analysis data were reviewed. Results The diagnosis was confirmed by molecular analysis in all patients. Fourteen out of sixteen patients were homozygous for the NPC1 p.G992W variant. Among them, most were categorized as having the late-infantile neurological form of disease onset. They predominantly manifested with early-onset visceral manifestations in the form of hepatosplenomegaly and prolonged neonatal jaundice, and late-onset neuropsychiatric manifestations in the form of vertical supranuclear gaze palsy (VSGP), ataxia, cognitive impairment and seizures. Brain MRI in 6 patients was normal in 5 or consistent with cerebellar hemisphere atrophy in 1 of them. Two other mutations were identified in the NPC1 gene, of which p.V845Cfs*24 was novel. Conclusions Our results revealed phenotypic heterogeneity of NPC even within the same genotype, and add to the increasingly recognized evidence that cholestatic jaundice and hepatosplenomegaly during infancy, should alert the physician for the possibility of NPC. We reported a novel mutation in the NPC1 gene further expanding its genotype.


Sign in / Sign up

Export Citation Format

Share Document